GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

20.53
Delayed Data
As of Aug 23
 0.00 / 0.00%
Today’s Change
18.14
Today|||52-Week Range
21.30
+9.51%
Year-to-Date
Top Analyst Reports for U.S. Bancorp, Duke Energy & Glaxo
Aug 23 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Looks to Partners to Pay the Bills
Aug 14 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit
Aug 23 / Zacks.com - Paid Partner Content
Should Value Investors Consider GlaxoSmithKline (GSK) Stock?
Aug 13 / Zacks.com - Paid Partner Content
Glaxo Submits First Regulatory Application for Daprodustat
Aug 22 / Zacks.com - Paid Partner Content
AnaptysBio Prepares for a Potential Gear Shift
Aug 10 / MotleyFool.com - Paid Partner Content
Better Buy: Eli Lilly vs. GlaxoSmithKline
Aug 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close20.53
Today’s open20.73
Day’s range20.53 - 20.75
Volume12,991
Average volume (3 months)3,816
Market cap$101.4B
Data as of 12:32pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.72%
P/E ratio15.2
Price/Sales2.30
Price/Book18.02

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Iain James Mackay
Corporate headquarters
Brentford, Greater London

Forecasts